Press release
Human Milk Oligosaccharides Market Report 2026-2036: High-Value Insights for Strategy, Product Development & Growth Planning
Human Milk Oligosaccharides Market
HMOs are gaining traction not only for their prebiotic and immune-boosting properties but also for emerging applications in adult health. Research highlights their role in long-term immune system modulation and gut-brain axis regulation, broadening their adoption across pediatric and adult nutrition markets.
Get Exclusive Access To Data Tables, Market Sizing Dashboards, And Analyst Insights. Request Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-4252
The market is witnessing strong momentum thanks to growing investments in HMO research, clinical validation, and supportive regulatory frameworks. Key HMOs, including 2'-FL, 3-FL, and LNnT, are being scaled up for production globally, ensuring wider availability and consistent quality.
Market Insights and Segmentation
• Leading Application Segment (2025): Infant Formula - 60% share
• Leading Product Segment: Fucosylated HMOs - 35% share
• Key Growth Region: Asia-Pacific (India, China, UK)
• Top Players: Chr. Hansen (Jennewein Biotechnologie), BASF, FrieslandCampina Ingredients, Abbott Nutrition, dsm-firmenich (Glycom)
HMOs represent approximately 50-55% of the infant formula ingredients market, mimicking the benefits of breast milk. In functional foods and beverages, they hold 3-5%, while in nutraceutical ingredients and prebiotics, their shares are 2-3% and 10-15%, respectively. Specialty sugars and biotechnology ingredients account for 1-2% of the HMO market, reflecting their high-value, bioengineered origins.
Recent innovations include plant-based HMO production using genetically engineered Nicotiana benthamiana, offering a sustainable and economically viable approach to large-scale synthesis of fucosylated, acidic, and neutral HMOs.
Semi-Annual Market Trends
• H1 2025-2035 CAGR: 6.5%
• H2 2025-2035 CAGR: 6.8%
This semi-annual analysis indicates a slight decrease in growth in the first half of 2025 followed by acceleration in H2, reflecting market stabilization and increased production efficiency.
Investment Focus: Key HMO Segments
Fucosylated HMOs are expected to secure a 35% market share by 2025 due to their critical role in immunity and gut health. Precision fermentation technologies are enabling commercial-scale production of 2ʹ-Fucosyllactose and related trisaccharides, providing benefits such as selective nourishment of beneficial Bifidobacterium species and pathogen inhibition.
Infant formula remains the dominant application, capturing 60% of the market, driven by growing demand for advanced breast milk alternatives. Multi-HMO blends like 2ʹ-Fucosyllactose and Lacto-N-neotetraose are increasingly incorporated to support immune, gut, and cognitive development.
• Asia-Pacific: Rapid premiumization, higher birth rates, and consumer willingness to invest in quality nutrition are driving growth.
• Europe and North America: Biotechnology collaborations and expanded production capacity ensure cost-efficient and reliable HMO supply.
Clinical studies in Spain, China, and across Europe reinforce HMO supplementation benefits, including improved cognitive function, gut health, and immune support in toddlers and infants.
Expanding HMO Applications
• Gut-Brain Axis Integration: HMOs are now being explored for their influence on neurodevelopment, stress response, and cognitive function, leading to multi-HMO formulations targeting brain health.
• Fermentation-Based Production: Microbial fermentation is improving cost efficiency and purity, making HMOs accessible for mid-tier brands and functional food applications.
• Regulatory Recognition: GRAS approvals and regulatory support in North America, Europe, and Asia-Pacific are facilitating global HMO adoption.
Country-Wise Insights
• USA: Growing functional beverage sector with HMO-infused RTD drinks and immune-boosting shakes. CAGR: 4.8%
• China: Customization of HMO blends for regional infant formula preferences. CAGR: 6.8%
• Germany: Expansion of medical nutrition using HMO-based therapeutics for gut microbiome and metabolic disorders. CAGR: 3.5%
Leading Suppliers
The HMO market is led by major biotech and nutrition companies such as:
• Chr. Hansen (Jennewein Biotechnologie) - Denmark/Germany
• BASF - Germany
• FrieslandCampina Ingredients - Netherlands
• Abbott Nutrition - USA
• dsm-firmenich (Glycom) - Denmark
• Nestlé Health Science - Switzerland
Specialized innovators like Inbiose, Kyowa Hakko Bio, ZuChem, and GlycoSyn are focusing on rare HMOs and scalable manufacturing methods, expanding applications in adult nutrition, dietary supplements, and functional foods.
Subscribe for Year-Round Insights → Stay ahead with quarterly and annual data updates! https://www.futuremarketinsights.com/reports/human-milk-oligosaccharides-market
Recent Industry Developments
• March 2024: DSM-Firmenich AG received USA and Australia regulatory approval for GlyCare 3-FL, enabling inclusion in functional foods and supplements.
• November 2024: Nestlé Health Science launched Wyeth Illume HMO-enriched milk in China, catering to premium infant nutrition demand.
Why FMI: https://www.futuremarketinsights.com/why-fmi
Browse Related Insights
Human Milk Oligosaccharides Market Share Analysis: https://www.futuremarketinsights.com/reports/human-milk-oligosaccharides-market-share-analysis
UK Human Milk Oligosaccharides Market: https://www.futuremarketinsights.com/reports/united-kingdom-human-milk-oligosaccharides-market
USA Human Milk Oligosaccharides Market: https://www.futuremarketinsights.com/reports/united-states-human-milk-oligosaccharides-market
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
Website: https://www.futuremarketinsights.com
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Human Milk Oligosaccharides Market Report 2026-2036: High-Value Insights for Strategy, Product Development & Growth Planning here
News-ID: 4326315 • Views: …
More Releases from Future Market Insights
Japan Caramel Food Colors Industry Outlook to 2036: Strategic Insights for R&D, …
The Japanese caramel food colors market is on a steady growth trajectory, with demand projected to rise from USD 11.2 million in 2025 to USD 28.4 million by 2035, registering a CAGR of 9.8%. The initial phase of the forecast period (2025-2030) anticipates a steady increase in demand, reaching approximately USD 17.8 million by 2030, driven by the expanding use of caramel colors across confectionery, dairy, and baked goods.
The market's…
Comprehensive Analysis of the Japan Butter Flavor Market: Technology Evolution, …
The demand for butter flavor in Japan is projected to rise from USD 16.1 million in 2025 to USD 29.4 million by 2035, reflecting a steady compound annual growth rate (CAGR) of 6.2%. This growth is underpinned by increasing adoption across bakery products, confectionery items, and dairy-based preparations, as manufacturers seek to enhance taste experiences and deliver authentic dairy character in a wide range of food offerings.
The Japanese bakery and…
Japan Casein Peptone Market Deep-Dive 2026-2036: Strategic Forecasts, Market Ent …
The demand for casein peptone in Japan is projected to grow steadily, reaching USD 27.1 million by 2035, up from USD 20.6 million in 2025, reflecting a compound annual growth rate (CAGR) of 2.8%. During the early forecast period (2025-2030), demand is expected to rise from USD 20.6 million to approximately USD 23.6 million, supported by its widespread applications in biotechnology, pharmaceuticals, and food industries. Casein peptone continues to play…
Global Boride Powder Market Size, Share & Forecast: High-Growth Segments, Value …
The global boride powder market is valued at USD 19.7 billion in 2025 and is projected to reach USD 32.2 billion by 2035, advancing at a steady 5.0% CAGR over the forecast period. This upward trajectory reflects increasing adoption of boride-based compounds in aerospace technology, high-temperature processing environments, and advanced coating applications, where exceptional thermal stability, corrosion resistance, and mechanical strength are essential for operational performance and product reliability.
Key Market…
More Releases for HMO
Human Milk Oligosaccharides (HMO) Market Share $332.6Million by 2028
According to a new report published by Allied Market Research, titled, "Human Milk Oligosaccharides (HMOs) Market by Type, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2028,"the global human milk oligosaccharides (HMO) market size was valued at $125.9 million in 2020, and is estimated to reach $332.6 million by 2028, registering a CAGR of 14.1% from 2021 to 2028.
Get a Sample PDF Report to understand our report before…
HMO Letting Agent Offers Comprehensive Guide on Finding Ideal HMO Properties
Image: https://lh7-us.googleusercontent.com/docsz/AD_4nXdeRv4NIF32OiXWyCk_Lgr-98A3ijzyBNqao0HtbwwKuAho9YNawZy2S1kszKE2N-k57rQrpogntqzJs2e8E6rcg2-3TToSnnOTitaEQnVfVwBF2yWUymqyLN8z5cTcDB2LHdA5ZVXm9usRTJtfDvkJvjO8?key=7pbbAt0GXq4x8JdfD2bfWw
If you're considering investing in property, HMO (House in Multiple Occupation) properties might be profitable. These properties are rental units shared by three or more tenants who aren't from the same household. They offer high rental yields and cater to the growing demand for shared accommodation. Working with an HMO Management Agency [https://hmolettingagent.co.uk/hmo-management/] can streamline the process and ensure compliance with legal requirements. This article will guide you through…
Human Milk Oligosaccharides (HMO) Market Insights and Future Outlook
According to a new report published by Allied Market Research, titled, "Human Milk Oligosaccharides (HMOs) Market by Type, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2028,"the global human milk oligosaccharides (HMO) market size was valued at $125.9 million in 2020, and is estimated to reach $332.6 million by 2028, registering a CAGR of 14.1% from 2021 to 2028.
📍𝐀𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 @ https://www.alliedmarketresearch.com/request-sample/A12027
💡𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐎𝐟𝐟𝐞𝐫…
How Big is Human Milk Oligosaccharides (HMO) Market?
The Global Human Milk Oligosaccharides (HMO) Market was valued at USD 196.5 million in 2022 and is projected to witness lucrative growth by reaching up to USD 850.5 million by 2030. The market is growing at a CAGR of 20.1% during the forecast period 2024-2031.
A new Report by DataM Intelligence, titled "Human Milk Oligosaccharides (HMO) Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis…
Human Milk Oligosaccharides (HMO) Market Regional Analysis & Forecast
The global Human Milk Oligosaccharides Market is estimated to be valued at USD 199 million in 2022. It is projected to reach USD 556 million by 2027, recording a CAGR of 22.7% during the forecast period.
The global HMO market has been influenced by some of the macroeconomic and microeconomic factors witnessed in some key countries. This would prove strong enough to drive the market significantly in terms of value…
Global Human Milk Oligosaccharides (HMO) Market Research Report 2016
This report studies Human Milk Oligosaccharides (HMO) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Beghin Meiji (France)
Beneo-Orafti SA (Belgium)
Cargill, Inc. (US)
Cosucra Groupe Warcoing SA (Belgium)
Ingredion Incorporated (US)
Royal Cosun (The Netherlands)
Sensus (The Netherlands)
Yakult Pharmaceutical Industry Co., Ltd. (Japan)
Major Manufacturers of Prebiotic Food Products
Abbott Nutrition (US)
Clasado BioSciences…
